Jeremie Nsengimana
Overview
Explore the profile of Jeremie Nsengimana including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
60
Citations
1261
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ugalde-Morales E, Wilf R, Pluta J, Ploner A, Fan M, Damra M, et al.
Am J Hum Genet
. 2025 Feb;
112(3):630-643.
PMID: 39999848
Transcriptome-wide association studies (TWASs) have the potential to identify susceptibility genes associated with testicular germ cell tumors (TGCTs). We conducted a comprehensive TGCT TWAS by integrating genome-wide association study (GWAS)...
2.
Noma I, Carvalho L, Camarena D, Silva R, Moraes Junior M, de Souza S, et al.
Biomed Pharmacother
. 2024 Jul;
177:116953.
PMID: 38955087
The second most common mutation in melanoma occurs in NRAS oncogene, being a more aggressive disease that has no effective approved treatment. Besides, cellular plasticity limits better outcomes of the...
3.
Gault A, Hogarth L, Williams K, Greystoke A, Rajan N, Speight A, et al.
BMC Cancer
. 2024 Jun;
24(1):733.
PMID: 38877461
Background: Checkpoint inhibitors (CPIs) are widely used in cancer treatment, with transformative impacts on survival. They nonetheless carry a significant risk of toxicity in the form of immune-related adverse events...
4.
Randerson-Moor J, Davies J, Harland M, Nsengimana J, Bigirumurame T, Walker C, et al.
J Invest Dermatol
. 2024 Apr;
144(11):2513-2529.e17.
PMID: 38583742
Peripheral blood transcriptomes from 383 patients with newly diagnosed melanoma were subjected to differential gene expression analysis. The hypotheses were that impaired systemic immunity is associated with poorer prognosis (thicker...
5.
Godson L, Alemi N, Nsengimana J, Cook G, Clarke E, Treanor D, et al.
Med Image Anal
. 2024 Feb;
93:103097.
PMID: 38325154
Determining early-stage prognostic markers and stratifying patients for effective treatment are two key challenges for improving outcomes for melanoma patients. Previous studies have used tumour transcriptome data to stratify patients...
6.
Tagore M, Hergenreder E, Perlee S, Cruz N, Menocal L, Suresh S, et al.
Cancer Discov
. 2023 Aug;
13(10):2270-2291.
PMID: 37553760
Significance: This study shows evidence of GABA-mediated regulation of electrical activity between melanoma cells and keratinocytes, providing a new mechanism by which the microenvironment promotes tumor initiation. This provides insights...
7.
Suresh S, Rabbie R, Garg M, Lumaquin D, Huang T, Montal E, et al.
Cancer Discov
. 2022 Oct;
13(1):194-215.
PMID: 36259947
Significance: We analyzed human melanoma transcriptomics data to identify a gene signature predictive of metastasis. To rapidly test clinical signatures, we built a genetic metastasis platform in adult zebrafish and...
8.
Castro M, Barbero G, Mascolo P, Villanueva M, Nsengimana J, Newton-Bishop J, et al.
J Cell Commun Signal
. 2022 Jun;
17(1):75-88.
PMID: 35723796
Receptor tyrosine kinase-like orphan receptor 2 (ROR2) is a protein with important functions during embryogenesis that is dysregulated in human cancer. An intriguing feature of this receptor is that it...
9.
Grasso C, Popovic M, Isaevska E, Lazzarato F, Fiano V, Zugna D, et al.
Cancer Epidemiol Biomarkers Prev
. 2022 Jun;
31(9):1769-1779.
PMID: 35700037
Background: Testicular germ cell tumors (TGCT), histologically classified as seminomas and nonseminomas, are believed to arise from primordial gonocytes, with the maturation process blocked when they are subjected to DNA...
10.
Garg M, Couturier D, Nsengimana J, Fonseca N, Wongchenko M, Yan Y, et al.
Nat Commun
. 2022 May;
13(1):2841.
PMID: 35581257
No abstract available.